NCT01858155View on ClinicalTrials.gov

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Relapsed Malignant Solid Tumor
Interventions
DRUG

Melatonin

Trial Locations (5)

T3B 6A8

Alberta Children's Hospital, Calgary

V6H 3V4

Children's & Women's Health Centre of British Columbia, Vancouver

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

M5G 1X8

The Hospital for Sick Children, Toronto

H3T 1C5

CHU Ste-Justine, Montreal

All Listed Sponsors
lead

C17 Council

OTHER

NCT01858155 - Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors | Biotech Hunter | Biotech Hunter